What does the evidence say about Psyllium Bowel Regularity Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Psyllium Bowel Regularity Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - In particular, it may be effective in the management of conditions such as hypertension, diabetes, and liver disease, alongside other potential health benefits, such as its ability to support gastrointestinal health, cardiovascular risk reduction, and metabolic control. [Sanlier Nevin (2026); evidence level 4] - Studies also emphasize its various metabolic and hepatoprotective effects, including the modulation of bile acid metabolism and the activation of pathways associated with the farnesoid X receptor. [Sanlier Nevin (2026); evidence level 4] - In an animal study conducted with rats, psyllium was found to have antioxidant and anti-inflammatory effects []. [Sanlier Nevin (2026); evidence level 4] - Plantago ovata 1 2 3 4 5 The shells or husks ofseeds, also known as psyllium, ispaghula, or isabgol, are attracting attention in recent years due to their health benefits [,]. [Sanlier Nevin (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.